GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenerative Medical Technology Group Inc (OTCPK:RMTG) » Definitions » PS Ratio

RMTG (Regenerative Medical Technology Group) PS Ratio : 0.19 (As of Mar. 05, 2025)


View and export this data going back to . Start your Free Trial

What is Regenerative Medical Technology Group PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Regenerative Medical Technology Group's share price is $0.0486. Regenerative Medical Technology Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.26. Hence, Regenerative Medical Technology Group's PS Ratio for today is 0.19.

The historical rank and industry rank for Regenerative Medical Technology Group's PS Ratio or its related term are showing as below:

RMTG' s PS Ratio Range Over the Past 10 Years
Min: 0.04   Med: 2.5   Max: 95
Current: 0.19

During the past 7 years, Regenerative Medical Technology Group's highest PS Ratio was 95.00. The lowest was 0.04. And the median was 2.50.

RMTG's PS Ratio is ranked better than
98.31% of 1003 companies
in the Biotechnology industry
Industry Median: 8.57 vs RMTG: 0.19

Regenerative Medical Technology Group's Revenue per Sharefor the three months ended in Sep. 2024 was $0.08. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.26.

Warning Sign:

Regenerative Medical Technology Group Inc revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Regenerative Medical Technology Group was 34.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 218.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 103.50% per year.

During the past 7 years, Regenerative Medical Technology Group's highest 3-Year average Revenue per Share Growth Rate was 218.60% per year. The lowest was -9.10% per year. And the median was 111.00% per year.

Back to Basics: PS Ratio


Regenerative Medical Technology Group PS Ratio Historical Data

The historical data trend for Regenerative Medical Technology Group's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerative Medical Technology Group PS Ratio Chart

Regenerative Medical Technology Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial 3.33 5.33 7.11 0.15 0.04

Regenerative Medical Technology Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.04 0.21 0.15 0.11

Competitive Comparison of Regenerative Medical Technology Group's PS Ratio

For the Biotechnology subindustry, Regenerative Medical Technology Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regenerative Medical Technology Group's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenerative Medical Technology Group's PS Ratio distribution charts can be found below:

* The bar in red indicates where Regenerative Medical Technology Group's PS Ratio falls into.



Regenerative Medical Technology Group PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Regenerative Medical Technology Group's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.0486/0.256
=0.19

Regenerative Medical Technology Group's Share Price of today is $0.0486.
Regenerative Medical Technology Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.26.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Regenerative Medical Technology Group  (OTCPK:RMTG) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Regenerative Medical Technology Group PS Ratio Related Terms

Thank you for viewing the detailed overview of Regenerative Medical Technology Group's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Regenerative Medical Technology Group Business Description

Traded in Other Exchanges
N/A
Address
433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc operates through its subsidiary. Its focus has been mainly dedicated to its operations serving the markets in the regenerative medicine industry. It believes stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.
Executives
Benito Novas 10 percent owner 433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
David Eugene Christensen director, 10 percent owner, officer: President and CEO 433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
Pereira Melvin Antonio Loria director, 10 percent owner, officer: CEO, Chairman RESIDENCIAL HACIENDA EL GREGAL, #24-1 SANCHEZ, CURRIDABAT, SAN JOSE G2 11803

Regenerative Medical Technology Group Headlines